Update Breast Cancer 2023 Part 2 – Advanced-Stage Breast Cancer

In recent years, a number of new therapies have led to advances in the treatment of patients with advanced breast carcinoma. These substances are mainly CDK4/6 inhibitors and other substances that can overcome endocrine resistance, oral selective estrogen receptor degraders, antibody drug conjugates...

Descripción completa

Detalles Bibliográficos
Autores principales: Lux, Michael P., Hartkopf, Andreas D., Fehm, Tanja N., Welslau, Manfred, Müller, Volkmar, Schütz, Florian, Fasching, Peter A., Janni, Wolfgang, Witzel, Isabell, Thomssen, Christoph, Beierlein, Milena, Belleville, Erik, Untch, Michael, Thill, Marc, Tesch, Hans, Ditsch, Nina, Aktas, Bahriye, Banys-Paluchowski, Maggie, Kolberg-Liedtke, Cornelia, Wöckel, Achim, Kolberg, Hans-Christian, Harbeck, Nadia, Bartsch, Rupert, Schneeweiss, Andreas, Ettl, Johannes, Würstlein, Rachel, Krug, David, Taran, Florin-Andrei, Lüftner, Diana, Stickeler, Elmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617389/
https://www.ncbi.nlm.nih.gov/pubmed/37916184
http://dx.doi.org/10.1055/a-2074-0125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617389/
https://www.ncbi.nlm.nih.gov/pubmed/37916184
http://dx.doi.org/10.1055/a-2074-0125

Ejemplares similares